Multi-mode Stroke Rehabilitation System: Development and Validation of Clinical Efficacy

NCT ID: NCT04441190

Last Updated: 2021-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-08-03

Study Completion Date

2021-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The specific study aims will be:

1. To develop the novel, digital, and interactive MSR system of arm and hand with integrated digital action observation therapy (AOT) and mirror therapy (MT).
2. To pilot usability testing for examining the feasibility of this new MSR system from the users' experiences and feedback.
3. To examine the treatment effects of digital AOT, digital MT and a control intervention in patients with stroke by conducting a randomized controlled trial.
4. To identify who will be the possible good responders to digital AOT and MT based on their baseline motor function and mental imagery abilities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Phase I: Multi-mode stroke rehabilitation (MSR) System Development \& Usability Testing

Ten patients with stroke and 4 certified occupational therapists were recruited in this phase I study. During the pilot testing, each stroke patient will try to use each training mode of digital AOT and MT by the assistance of the therapist. At the end of the pilot testing, the patients and the therapists will be asked to complete the System Usability Scale and a self-designed questionnaire to assess the user experience and perspective about this new MSR system and their view of its suitability for stroke patients.

Phase II: Validation of Clinical Treatment Efficacy

This three-arm, single-blind, randomized controlled trial will investigate the treatment effects among the 3 groups of digital AOT, digital MT, and dose-matched control intervention. An estimated 60 patients with stroke will be recruited to participate in this phase II study. Each participant will receive a total of 15 training sessions (60 minutes per session) for 3 to 4 weeks. Clinical outcome measures will be conducted at baseline, immediately after treatment (the fourth week), and at 1 month follow-up after treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Cerebrovascular Disorders Central Nervous System Diseases

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

stroke multi-mode rehabilitation action observation mirror therapy digital image technology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Digital Action Observation Therapy (Digital AOT)

The common categories of motor actions and tasks will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movement or object manipulation, and (c) upper-limb functional tasks.

Group Type EXPERIMENTAL

Digital Action Observation Therapy (Digital AOT)

Intervention Type BEHAVIORAL

The participants will be asked to observe videos and then practice what the participants observed.

Digital Mirror Therapy (Digital MT)

The common categories of motor actions and tasks will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movement or object manipulation, and (c) upper-limb functional tasks.

Group Type EXPERIMENTAL

Digital Mirror Therapy (Digital MT)

Intervention Type BEHAVIORAL

The participants will observe the real-time self-recorded visual illusion, and move their upper limbs as could as possible.

Conventional Occupational Therapy

The common categories of motor actions and tasks will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movement or object manipulation, and (c) upper-limb functional tasks.

Group Type ACTIVE_COMPARATOR

Conventional Occupational Therapy

Intervention Type BEHAVIORAL

The participants will receive upper-limb training without providing videos for observing neither providing them mirror illusions of movements.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Digital Action Observation Therapy (Digital AOT)

The participants will be asked to observe videos and then practice what the participants observed.

Intervention Type BEHAVIORAL

Digital Mirror Therapy (Digital MT)

The participants will observe the real-time self-recorded visual illusion, and move their upper limbs as could as possible.

Intervention Type BEHAVIORAL

Conventional Occupational Therapy

The participants will receive upper-limb training without providing videos for observing neither providing them mirror illusions of movements.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosed as having a unilateral stroke;
* aged from 20 to 80 years;
* a baseline score of the Fugl-Meyer Assessment in a range of 20 to 60;
* able to follow the instructions and able to provide user feedback verbally;
* without aphasia and neglect

For therapists


* holding an occupational therapist license

Phase II: Validation of Clinical Treatment Efficacy


* diagnosed as having a unilateral stroke;
* at least 6 months after stroke onset;
* aged from 20 to 80 years;
* a baseline score of FMA in a range of 20 to 60;
* able to follow the study instructions;
* capable of participating in therapy and assessment sessions

Exclusion Criteria

* global or receptive aphasia,
* severe neglect,
* major medical problems or comorbidities that have influenced upper-limb usage or caused severe pain
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chang Gung Memorial Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yu-Wei Hsieh, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Occupational Therapy, College of Medicine, Chang Gung University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taipei Hospital, Ministry of Health and Welfare

New Taipei City, , Taiwan

Site Status

Taoyuan Chang Gung Memorial Hospital

Taoyuan, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

References

Explore related publications, articles, or registry entries linked to this study.

Hsieh YW, Lee MT, Hsu YC, Wu KY, Chen CC. Digital Mirror Therapy and Action Observation Therapy for Chronic Stroke: A Pilot Randomized Controlled Trial. Occup Ther Int. 2025 Mar 20;2025:8741362. doi: 10.1155/oti/8741362. eCollection 2025.

Reference Type DERIVED
PMID: 40151488 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201901885A3

Identifier Type: -

Identifier Source: org_study_id